EXICURE, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
EXICURE, INC. (XCUR) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 87.20 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-03-11
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 87.33M shares, a 13.29% increase year-over-year.
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 87.23M shares, a 34.92% increase year-over-year.
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 87.17M shares, a 96.48% increase year-over-year.
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-12-31 was 77.09M shares, a 73.65% increase year-over-year.
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 87.20M shares, a 51.21% increase from fiscal 2019.
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 57.67M shares, a 40.02% increase from fiscal 2018.
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 41.19M shares, a 307.03% increase from fiscal 2017.
- EXICURE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 10.12M shares, a 8822.37% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | 87.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 87.28M shares derived: average of 2 quarters · filed 2021-03-11 | 87.24M shares derived: average of 3 quarters · filed 2021-03-11 | 87.20M shares 10-K · filed 2021-03-11 |
| 2020-09-30 | 87.23M shares 10-Q · filed 2020-11-12 | 87.20M shares derived: average of 2 quarters · filed 2020-11-12 | 87.16M shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 87.17M shares 10-Q · filed 2020-08-12 | 87.13M shares 10-Q · filed 2020-08-12 | ||
| 2019-12-31 | 77.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 70.87M shares derived: average of 2 quarters · filed 2021-03-11 | 62.04M shares derived: average of 3 quarters · filed 2021-03-11 | 57.67M shares 10-K · filed 2021-03-11 |
| 2019-09-30 | 64.65M shares 10-Q · filed 2020-11-12 | 54.51M shares derived: average of 2 quarters · filed 2020-11-12 | 51.20M shares 10-Q · filed 2020-11-12 | 49.44M shares derived: average of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | 44.37M shares 10-Q · filed 2020-08-12 | 44.36M shares 10-Q · filed 2020-08-12 | 44.37M shares derived: average of 3 quarters · filed 2020-08-12 | 43.66M shares derived: average of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | 44.36M shares 10-Q · filed 2019-05-08 | 44.38M shares derived: average of 2 quarters · filed 2020-03-10 | 43.43M shares derived: average of 3 quarters · filed 2020-03-10 | 42.43M shares derived: average of 4 quarters · filed 2020-03-10 |
| 2018-12-31 | 44.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 42.96M shares derived: average of 2 quarters · filed 2020-03-10 | 41.79M shares derived: average of 3 quarters · filed 2020-03-10 | 41.19M shares 10-K · filed 2020-03-10 |
| 2018-09-30 | 41.53M shares 10-Q · filed 2019-11-07 | 40.49M shares derived: average of 2 quarters · filed 2019-11-07 | 40.12M shares 10-Q · filed 2019-11-07 | 40.07M shares derived: average of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | 39.45M shares 10-Q · filed 2019-08-08 | 39.41M shares 10-Q · filed 2019-08-08 | 39.58M shares derived: average of 3 quarters · filed 2019-09-23 | 30.12M shares derived: average of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | 39.36M shares 10-Q · filed 2019-05-08 | 39.64M shares derived: average of 2 quarters · filed 2019-09-23 | 27.00M shares derived: average of 3 quarters · filed 2019-09-23 | |
| 2017-12-31 | 39.93M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | 20.83M shares derived: average of 2 quarters · filed 2019-09-23 | 10.12M shares 10-K/A · filed 2019-09-23 | |
| 2017-09-30 | 1.73M shares 10-Q · filed 2018-11-06 | 183.40K shares 10-Q · filed 2018-11-06 | ||
| 2017-08-31 | 1.21M shares 10-Q · filed 2017-09-12 | 1.10M shares 10-Q · filed 2017-09-12 | ||
| 2017-06-30 | 190.08K shares 10-Q · filed 2018-08-06 | 180.00K shares 10-Q · filed 2018-08-06 | ||
| 2017-05-31 | 1.00M shares 10-Q · filed 2017-07-11 | |||
| 2017-03-31 | 169.79K shares 10-Q · filed 2018-05-15 | 147.42K shares derived: average of 2 quarters · filed 2018-05-15 | 130.85K shares derived: average of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | 125.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | 111.37K shares derived: average of 2 quarters · filed 2018-03-09 | 113.42K shares 10-K · filed 2018-03-09 | |
| 2016-09-30 | 97.69K shares 10-Q · filed 2017-11-14 | 109.54K shares 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |